Rituximab and bendamustine in patients with CD20+ diffuse large B-cell lymphoma not eligible for cyclophosphamide, doxorubicin, vincristine and prednisone-like chemotherapy

Saved in:
Bibliographic Details
Main Authors: Walter, Eva (Author) , Schmitt, Thomas (Author) , Dietrich, Sascha (Author) , Ho, Anthony Dick (Author) , Witzens-Harig, Mathias (Author)
Format: Article (Journal)
Language:English
Published: 22 May 2012
In: Leukemia and lymphoma
Year: 2012, Volume: 53, Issue: 11, Pages: 2290-2292
ISSN:1029-2403
DOI:10.3109/10428194.2012.682311
Online Access:Verlag, Volltext: http://dx.doi.org/10.3109/10428194.2012.682311
Verlag, Volltext: https://doi.org/10.3109/10428194.2012.682311
Get full text
Author Notes:Eva Walter, Thomas Schmitt, Sascha Dietrich, Anthony Ho, Mathias Witzens-Harig
Description
Item Description:Gesehen am 12.02.2019
Physical Description:Online Resource
ISSN:1029-2403
DOI:10.3109/10428194.2012.682311